The role of mast cell-derived secreted phospholipases A2 in respiratory allergy

Biochimie

Volumn 92, Issue 6, 2010, Pages 588-593

  Granata, Francescopaolo ^a   Staiano, Rosaria Ilaria ^a   Loffredo, Stefania ^a   Petraroli, Angelica ^a   Genovese, Arturo ^a   Marone, Gianni ^a   Triggiani, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Allergic inflammation; Asthma; Eicosanoids; Mast cells; Secreted phospholipases A2

Indexed keywords

GELATINASE A; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE C4; LY 333013; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRILYSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE A2 GROUP IB; PHOSPHOLIPASE A2 GROUP II; PHOSPHOLIPASE A2 GROUP III; PHOSPHOLIPASE A2 GROUP V; PHOSPHOLIPASE A2 GROUP X; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN D2; PROTEOHEPARAN SULFATE; S 3013; SECRETORY PHOSPHOLIPASE A2; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ASTHMA; AUTOCRINE EFFECT; BACTERIAL IMMUNITY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME RELEASE; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MAST CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SHORT SURVEY; VIRUS IMMUNITY;

ANIMALS; ASTHMA; HUMANS; LUNG; MAST CELLS; MODELS, BIOLOGICAL; PHOSPHOLIPASES A2, SECRETORY; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYSTEM;

EID: 77953292541     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.02.030     Document Type: Short Survey

References (65)

1. 2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
2. 2. Annu. Rev. Biochem. 2008, 77:495-520.
3. 2 in inflammatory and allergic diseases: not just enzymes. J. Allergy Clin. Immunol. 2005, 116:1000-1006.
4. 2 as multivalent mediators of inflammatory and allergic disorders. Int. Arch. Allergy Immunol. 2003, 131:153-163.
5. 2. Biochim. Biophys. Acta 2006, 1761:1289-1300.
6. 2 in human bronchoalveolar lavage fluid. Exp. Lung Res. 1996, 22:299-315.
7. 2 from human nasal lavage. Am. J. Respir. Cell. Mol. Biol. 1994, 11:108-113.
8. 2: a proinflammatory connection between macrophages and mast cells in the human lung. Immunobiology 2009, 214:811-821.
9. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 1997, 155:421-425.
10. Chilton F.H., Averill F.J., Hubbard W.C., Fonteh A.N., Triggiani M., Liu M.C. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 1996, 183:2235-2245.
11. 2 enzymes. Prostaglandins Other Lipid Mediat. 2002, 68-69:3-58.
12. 2 in rodents during inflammation. Biochim. Biophys. Acta 2003, 1635:37-47.
13. 2 enzymes in several human tissues. Biochim. Biophys. Acta 2005, 1736:200-210.
14. 2 group X overexpression in asthma and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2007, 176:1072-1078.
15. 2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps. Allergy 2007, 62:999-1006.
16. Marone G., Lichtenstein L.M., Galli S.J. Mast Cells and Basophils 2000, Academic Press, San Diego, 707 pp.
17. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008, 8:478-486.
18. Mekori Y.A., Metcalfe D.D. Mast cells in innate immunity. Immunol. Rev. 2000, 173:131-140.
19. 2. J Allergy Clin. Immunol. 2009, 124:558-565. 565 e551-553.
20. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 2007, 204:865-877.
21. 2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J. Immunol. 2007, 179:4800-4807.
22. 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem. J. 2005, 387:27-38.
23. 2 family of enzymes in human nasal mucosa. Eur. Respir. J. 2001, 18:130-138.
24. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J. Immunol. 1994, 152:5438-5446.
25. 2 levels in murine mast cells by recombinant stem cell factor. J. Clin. Invest. 1995, 96:1432-1439.
26. Bingham C.O., Fijneman R.J., Friend D.S., et al. Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cells. J. Biol. Chem. 1999, 274:31476-31484.
27. 2 that mediates prostaglandin production in mast cells. J. Biol. Chem. 1997, 272:13591-13596.
28. 2 synthesis in mast cells. J. Immunol. 2000, 165:4007-4014.
29. 2 antigen in arthritic synovium. Ann. Rheum. Dis. 1998, 57:550-558.
30. 2 in mast cells and macrophages in normal human ileal submucosa and in Crohn's disease. Clin. Chem. Lab. Med. 2000, 38:1231-1236.
31. Kirshenbaum A.S., Akin C., Wu Y., et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of Fce{open}RI or FcγRI. Leuk. Res. 2003, 27:677-682.
32. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 2002, 277:5061-5073.
33. 2. Blood 1998, 91:3037-3043.
34. 2α in arachidonic acid release and platelet activating factor synthesis. Biochim. Biophys. Acta 2009, 1791:92-102.
35. 4 release. J. Pharmacol. Exp. Ther. 1998, 284:847-857.
36. 2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J. Biol. Chem. 1999, 274:29927-29936.
37. 2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 2001, 276:10083-10096.
38. 2 in eicosanoid generation by mouse bone marrow-derived mast cells. Adv. Exp. Med. Biol. 2002, 507:41-46.
39. 2 independently of sphingosine-1-phosphate receptors. Blood 2007, 109:1077-1085.
40. 2 in murine bone marrow-derived mast cells. J. Immunol. 2000, 165:2773-2782.
41. 2α activation. Blood 2007, 110:561-567.
42. 2. Biochem. Biophys. Res. Commun. 2002, 292:689-696.
43. 2 to the mouse M-type receptor. Biochemistry 2007, 46:1647-1662.
44. 2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2. J. Biol. Chem. 2002, 277:36479-36488.
45. 2. J. Immunol. 1993, 151:5675-5684.
46. 2 isotypes. J. Immunol. 2001, 167:4161-4171.
47. 2. J. Biol. Chem. 2002, 277:19145-19155.
48. 2-induced contractions of guinea pig lung pleural strips. Eur. J. Pharmacol. 1992, 216:87-96.
49. 2. Am. Rev. Respir. Dis. 1992, 145:1463-1468.
50. Marone G., Austen K.F., Holgate S.T., Kay A.B., Lichtenstein L.M. Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment 2004, Blackwell, London.
51. Akdis C.A., Blaser K. Histamine in the immune regulation of allergic inflammation. J. Allergy Clin. Immunol. 2003, 112:15-22.
52. Park G.Y., Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290:L797-L805.
53. Peters-Golden M., Henderson W.R. Leukotrienes. N. Engl. J. Med. 2007, 357:1841-1854.
54. 2 induces dendritic cell maturation. Eur. J. Immunol. 2004, 34:2293-2302.
55. 2. Blood 2005, 105:3583-3587.
56. 2 preferentially expressed in type 2 helper T cells. J. Biol. Chem. 2001, 276:18321-18326.
57. Tessier C., Hichami A., Khan N.A. Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett. 2002, 520:111-116.
58. 2 in human lung macrophages. Eur. J. Immunol. 2006, 36:1938-1950.
59. 2 in human lung macrophages expressing the M-type receptor. J. Immunol. 2005, 174:464-474.
60. 2 activate selective functions in human eosinophils. J. Immunol. 2003, 170:3279-3288.
61. 2: a role for cell surface glycosaminoglycans. Biochem. Pharmacol. 2002, 63:65-72.
62. Rizzo M.T., Nguyen E., Aldo-Benson M., Lambeau G. Secreted phospholipase A(2) induces vascular endothelial cell migration. Blood 2000, 96:3809-3815.
63. 2 inhibitor on inhaled allergen challenge in subjects with asthma. J. Asthma 2005, 42:65-71.
64. 2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection. Crit. Care Med. 2001, 29:719-727.
65. 2 inhibitor: a new class of anti-inflammatory drugs, SPI. J. Pharmacol. Exp. Ther. 1999, 288:1117-1124.